Ophthotech Corp (NASDAQ:OPHT)‘s stock had its “buy” rating reiterated by stock analysts at Stifel Nicolaus in a report issued on Wednesday. They currently have a $59.00 price target on the stock, up from their previous price target of $58.00. Stifel Nicolaus’ price target would suggest a potential upside of 34.46% from the company’s current price. Ophthotech Corporation (NASDAQ:OPHT) belongs to Healthcare sector. Its weekly performance … Continue reading Morning Buzz: Ophthotech Corporation (NASDAQ:OPHT), Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK), National Security Group Inc. (NASDAQ:NSEC), SJW Corp. (NYSE:SJW), Semler Scientific Inc (NASDAQ:SMLR)